FXIII Concentrate (Human) ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
288	Autoimmune acquired coagulation factor deficiency	3

288. Autoimmune acquired coagulation factor deficiency

---

Clinical trials : 206 /  Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00945906 (ClinicalTrials.gov)	September 2009	23/7/2009	An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	A Prospective, Multicenter, Open Enrollment Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	Factor XIII Deficiency	Biological: FXIII Concentrate (Human) (FXIII)	CSL Behring	NULL	Completed	N/A	N/A	All	61	Phase 3	United States
2	NCT00885742 (ClinicalTrials.gov)	August 2009	21/4/2009	A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	Factor XIII Deficiency	Biological: FXIII Concentrate (Human)	CSL Behring	NULL	Completed	N/A	N/A	All	41	Phase 3	United States;Spain
3	NCT00883090 (ClinicalTrials.gov)	May 2009	16/4/2009	A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency	A 12 Week, Multicenter, Pharmacokinetic and Safety Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency	Factor XIII Deficiency	Biological: FXIII Concentrate (Human)	CSL Behring	NULL	Completed	N/A	N/A	All	15	Phase 2	United States;Spain